VRAX · Virax Biolabs Group Ltd · Documents
Market Cap
$1.78M
Shares
1.34M
Volume · Oct 22
14.56K
Avg daily vol (3M)
392.65K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| F-3 | — | 2023-12-05 | — | |
| 6-K | — | 2023-11-08 | — | |
| 6-K | — | 2023-10-31 | — | |
| 6-K | — | 2023-10-12 | — | |
| 6-K | — | 2023-10-04 | — | |
| 6-K | — | 2023-09-12 | — | |
| 6-K | — | 2023-09-01 | — | |
| 6-K | — | 2023-08-03 | — | |
| 6-K | — | 2023-07-18 | — | |
| 20-F | — | 2023-06-14 | 2023-03-31 | |
| 6-K | — | 2023-06-14 | — | |
| 6-K | — | 2023-05-04 | — | |
| 6-K | — | 2023-04-21 | — | |
| 6-K | — | 2023-04-19 | — | |
| F-1 | — | 2023-03-22 | — | |
| 6-K | — | 2023-03-10 | — | |
| 6-K | — | 2023-03-07 | — | |
| 6-K | — | 2023-02-07 | — | |
| 6-K | — | 2023-02-02 | — | |
| 6-K | — | 2023-02-02 | — | |
| 6-K | — | 2023-01-04 | — | |
| 6-K | — | 2022-12-06 | — | |
| F-1 | — | 2022-11-21 | — | |
| 6-K | — | 2022-11-18 | — | |
| 6-K | — | 2022-11-15 | — | |
| 6-K | — | 2022-11-08 | — | |
| 6-K | — | 2022-11-03 | — | |
| 6-K | — | 2022-10-26 | — | |
| 6-K | — | 2022-09-22 | — | |
| 6-K | — | 2022-09-20 | — | |
| 6-K | — | 2022-09-12 | — | |
| 6-K | — | 2022-09-07 | — | |
| 20-F | — | 2022-08-12 | 2022-03-31 | |
| NT 20-F | — | 2022-07-29 | 2022-03-31 | |
| 6-K | — | 2022-07-29 | — | |
| 6-K | — | 2022-07-26 | — | |
| F-1/A | — | 2022-06-27 | — | |
| F-1/A | — | 2022-06-24 | — | |
| F-1/A | — | 2022-06-21 | — | |
| F-1/A | — | 2022-06-07 | — | |
| F-1/A | — | 2022-05-11 | — | |
| F-1/A | — | 2022-04-25 | — | |
| F-1 | — | 2022-03-18 | — |
Showing 51–93 of 93 filings